The Canadian Supreme Court has issued another decision that recognized the limits of intellectual property.  This case, a pharmaceutical patent fight between AstraZeneca and Apotex, includes language from the court that explicitly warns against the practice of evergreening, whereby pharmaceutical companies seek to extend the life of patent protection by […]

Read more ›